COST-EFFECTIVENESS OF DENOSUMAB VS. ZOLEDRONIC ACID IN A POPULATION 75 YEARS OR OLDER IN THE US

被引：0
作者：
Stolshek, Brad [1 ]
Kruse, Morgan [2 ]
Yurgin, Nicole [3 ]
Huang, Joice [4 ]
Ho, Pei-Ran [4 ]
Wang, Andrea [4 ]
Parthan, Anju [2 ]
Taylor, Doug [2 ]
机构：
[1] Amgen Inc, Cambridge, England
[2] OptumInsight, Eden Prairie, MN USA
[3] Amgen Inc, Global Hlth Econ, Thousand Oaks, CA 91320 USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S137 / S138
页数：2
相关论文
共 50 条
[31]   Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia [J].
Ascher-Svanum, Haya ;
Stensland, Michael D. ;
Peng, Xiaomei ;
Faries, Douglas E. ;
Stauffer, Virginia L. ;
Osuntokun, Olawale O. ;
Kane, John M. .
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) :115-122
[32]   Indoor Localization: A Cost-Effectiveness vs. Accuracy Study [J].
Mohebbi, Parisa ;
Stroulia, Eleni ;
Nikolaidis, Ioanis .
2017 IEEE 30TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS (CBMS), 2017, :552-557
[33]   Response to: Ranibizumab vs. pegaptanib: a cost-effectiveness study? [J].
Luis Javier Hernández-Pastor .
Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 :1677-1677
[34]   Response to: Ranibizumab vs. pegaptanib: a cost-effectiveness study? [J].
Javier Hernandez-Pastor, Luis .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (11) :1677-1677
[35]   Cost-effectiveness of Olanzapine vs. lithium in bipolar disorder [J].
Schaerer, LO ;
Berns, S ;
Born, C ;
Brambilla, P ;
Dobmeier, M ;
Doppmann, T ;
Graf, M ;
Hartweg, V ;
Hasmann, A ;
Langosch, J ;
Gerber, S ;
Malliaris, Y ;
Scott, HJ ;
Seemüller, F ;
Simhandl, C ;
Torrent, C ;
Trapp, W ;
Wolf, J ;
Grunze, H .
ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 :35-35
[36]   Cost-effectiveness of risedronate vs. Ibandronate: impact of persistence [J].
Grima, D. ;
Pasquale, M. ;
Lange, J. ;
Thompson, M. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 :S157-S158
[37]   Cost-effectiveness modeling of dental implant vs. bridge [J].
Bouchard, P. ;
Renouard, F. ;
Bourgeois, D. ;
Fromentin, O. ;
Jeanneret, M. H. ;
Beresniak, A. .
CLINICAL ORAL IMPLANTS RESEARCH, 2009, 20 (06) :583-587
[38]   Cost-effectiveness of risedronate vs. ibandronate: Impact of discounts [J].
Grima, D. ;
Borisov, N. N. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 :S442-S442
[39]   COST EFFECTIVENESS OF ZOLEDRONIC ACID VS. PAMIDRONATE OR NO THERAPY FOR THE TREATMENT OF BONE METASTASES SECONDARY TO PROSTATE CANCER [J].
Carter, J. A. ;
Bains, M. ;
Chandiwana, D. ;
Kaura, S. ;
Botteman, M. F. .
VALUE IN HEALTH, 2011, 14 (07) :A447-A447
[40]   Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome [J].
van den Broek, Wout W. A. ;
van Paassen, Jacqueline G. ;
Gimbel, Marieke E. ;
Deneer, Vera H. M. ;
Ten Berg, Jurrien M. ;
Vreman, Rick A. .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) :76-84
12345